Answers are grounded in this paper and cite their sources.
1] Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling ... [2] National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980 ... [3] Global burden of diabetes, 1995-2025: Prevalence ... [4] Diabetes in Iran: Prospective analysis from first nationwide ... [5] Projection of diabetes population size and associated ... [6] The direct medical costs of outpatient cares of type 2 diabetes in ... [7] Prevention or delay of type 2 diabetes: Standards ... [8] Iran Diabetes Research Roadmap (IDRR) study ... [9] Epidemiology of diabetes mellitus ... [10] Higher prevalence of diabetes mellitus and impaired glucose tolerance ... [11] Diagnosis and classification of diabetes ... [12] Classification and diagnosis of diabetes: Standards ... [13] Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic ... [14] Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in ... [15] Prevalence of diabetes and prediabetes according to fasting plasma ... [16] Tools for practice: Screening and diagnosis of type 2 ... [17] HbA 1c as a diagnostic test for diabetes mellitus -reviewing ... [18] Body mass index and obesity: Tailoring "cut-off" for ... [19] Why screening for type 2 diabetes is necessary even ... [20] Screening for ... [21] Screening for diabetes with HbA1c: Test performance of HbA1c compared ... [22] Screening for abnormal blood glucose and type 2 ... [23] IDF diabetes atlas: Global estimates for the prevalence of ... [24] High prevalence of diabetes and abnormal ... [25] Third national Surveillance of Risk Factors of Non-Communicable ... [26] The prevalence of pre-diabetes and diabetes in the Kuwaiti adult ... [27] Prevalence of type 2 diabetes mellitus in a sample of the adult ... [28] The prevalence and management of diabetes in ... [29] The comparison of prevalence of diabete and hypertension ... [30] Optimal Glycated hemoglobin cutoff ... [31] Diabetes in older ... [32] Prevalence of and trends in diabetes among ... [33] Correlates of age onset of type 2 diabetes ... [34] Prevalence of type 2 diabetes mellitus in Iran and its ... [35] The correlation of HbA1c with body mass index and ... [36] Correlation of HbA1C levels with body ... [37] Familial history of diabetes and clinical ... [38] Family history of type 2 diabetes: A population-based ... Aims To find prevalence and related factors of diabetes mellitus in rural regions of Grash Town located in central Iran (Fars province) composed of 25 rural regions.Instruments & Methods This cross sectional study was conducted on a sample of 1523 adults aged ≥30 years, living in rural regions of Grash Town during 2015-2016.We used stratified random sampling.Participants were invited by calls and informed consent was obtained from all.We checked HbA1c of participants and demographic information, past medical history, and some risk factors (BMI, familial and personal history of diabetes and level of physical activity) among them were investigated.Cases with HbA1C≥6.5% were considered diabetics.Pregnant women and people with haemoglobinopathies, anemias, and chronic liver/renal diseases were excluded.Data were analyzed, using SPSS19 software.Statistical significant level was <0.05 in this study.Findings In this study, 507(33.3%)cases were with HbA1c≥6.5%, of whom 241 (15.8%) were previously diagnosed as diabetic.Diabetes was associated with age (p<0.001),occupation (p=0.04),education (p<0.001),marital status (p<0.001),BMI (p<0.001), and familial history (p<0.001).Age ≥ 50 years, familial history of diabetes, obesity/overweight, unemployment, low educational attainment, and loss of partner were all more frequent in diabetics.Conclusion Prevalence of diabetes measured by HbA1c in this study was greater than most previous studies in Iran.However, most studies have used FBS and we need further studies to determine optimal threshold of HbA1c for diagnosis of diabetes in Iranian population.High risk people should be focused in preventive and control programs.
No takes yet. Share an insight, caveat, or question.
Soori et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: